Laurell C B, Rannevik G
J Clin Endocrinol Metab. 1979 Nov;49(5):719-25. doi: 10.1210/jcem-49-5-719.
Analysis of 25 plasma proteins was performed on blood drawn from 7 females before and during treatment with danazol. This steroid was found to induce a pattern of plasma protein changes similar to but not identical with that of other 17 alpha-alkylated anabolic steroids. For comparison, the same 25 plasma proteins were analyzed in blood from pregnant women in their third trimester, when the estrogen influence on plasma protein synthesis is most pronounced. Five major types of response were found. 1) Albumin and orosomucoid were not influenced by danazol or, after correction for volume expansion, by pregnancy. 2) Prealbumin, C1-esterase inhibitor, and haptoglobins increased substantially during danazol treatment but were not significantly influenced by pregnancy. 3) Transferrin, antithrombin III, prothrombin, and plasminogen showed marked increases after administration of danazol and during pregnancy. 4) Transcortin, ceruloplasmin, and alpha 1-antitrypsin doubled in pregnancy but were not influenced by danazol. 5) The concentrations of T4-binding globulin, pregnancy zone protein, and sex hormone-binding globulin more than doubled in pregnancy, and all three decreased to one third or less on administration of danazol. The plasma estradiol content fell correspondingly. The different types of plasma protein response found in these two groups of patients fit the hypothesis that hepatocytes contain steroid receptors capable of reacting with estrogens and/or other steroids such as danazol and, thus, influence the biosynthetic rate of many but not all plasma proteins according to a specific pattern. The synthesis of some of the estrogen-sensitive proteins is depressed after intake of danazol, which suggests that there is a competition for the receptors in the hepatocytes as there is for other estrogen target tissues.
对7名女性在服用达那唑治疗前和治疗期间抽取的血液进行了25种血浆蛋白分析。发现这种类固醇诱导的血浆蛋白变化模式与其他17α-烷基化合成代谢类固醇相似但不完全相同。为作比较,对妊娠晚期孕妇血液中的相同25种血浆蛋白进行了分析,此时雌激素对血浆蛋白合成的影响最为明显。发现了五种主要类型的反应。1)白蛋白和类粘蛋白不受达那唑影响,在纠正容量扩张后也不受妊娠影响。2)前白蛋白、C1酯酶抑制剂和触珠蛋白在达那唑治疗期间大幅增加,但不受妊娠显著影响。3)转铁蛋白、抗凝血酶III、凝血酶原和纤溶酶原在服用达那唑后和妊娠期间均显著增加。4)皮质类固醇结合球蛋白、铜蓝蛋白和α1抗胰蛋白酶在妊娠期间增加一倍,但不受达那唑影响。5)甲状腺素结合球蛋白、妊娠区蛋白和性激素结合球蛋白的浓度在妊娠期间增加一倍以上,而在服用达那唑后均降至三分之一或更低。血浆雌二醇含量相应下降。在这两组患者中发现的不同类型的血浆蛋白反应符合以下假设:肝细胞含有能够与雌激素和/或其他类固醇(如达那唑)反应的类固醇受体,从而根据特定模式影响许多但不是所有血浆蛋白的生物合成速率。摄入达那唑后,一些对雌激素敏感的蛋白的合成受到抑制,这表明肝细胞中的受体存在竞争,就像在其他雌激素靶组织中一样。